CDKN1A and melanoma: Our previous study also reveals that both mRNA and protein levels of p21 is significant declined after tigecycline treatment in a dose- and time-dependent manner, and restoration of p21 in melanoma can rescue cell cycle arrest, cell proliferation inhibition, migration, and migration blockade induced by tigecycline treatment [25].